Henry Schein Inc (HSIC) — Analysis Summary
Henry Schein Inc (HSIC) has a market cap of $9.39B with year-over-year revenue growth of +4.0%. Net margin stands at 3.0%. The stock trades at a P/E ratio of 23.3.
Key Takeaways
- Revenue changed +4.0% year-over-year
- Net margin of 3.0%
- P/E ratio of 23.3
Compared to other companies in the WHOLESALE-MEDICAL, DENTAL & HOSPITAL EQUIPMENT & SUPPLIES sector, HSIC posted revenue growth of +4.0% and trades at a P/E of 23.3.
Henry Schein Inc (HSIC)
PREVIOUS CLOSE 2026-10-12 · MARKET DATA POLYGON · FINANCIALS SEC EDGAR
Red Flags & WarningsNo Major Flags
No major credit, margin, or trend red flags were triggered from the latest filings.
Henry Schein Inc is a solutions company for healthcare professionals. It offers healthcare equipment, products, and services to office-based dental and medical practitioners, as well as alternative sites of care. The company's reportable segments are: Global Distribution and Value-Added Services, Global Specialty Products, and Global Technology. It generates maximum revenue from the Global Distribution and Value-Added Services segment, which includes distribution to the dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services. This segment also includes value-added services such as financial services, continuing education services, consulting, and other practice services.
Sector
WHOLESALE-MEDICAL, DENTAL & HOSPITAL EQUIPMENT & SUPPLIES
Employees
25,000
Headquarters
MELVILLE, NY
Exchange
XNAS
Systematic competitive advantage assessment based on 4yr data
This assessment is based on quantitative analysis of historical financial data and does not constitute investment advice. Moat ratings may change with industry and competitive dynamics.
First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.
Capital Structure
Cash Flow
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.